alexis ohanian glp 1 Serena Williams has sparked intense outrage after partnering with the telehealth company Ro to promote GLP-1 medications, similar to Ozempic. The controversy arises because her husband, Ohanian, is a prominent investor Serena's weight loss secret is

PlushCare reviews are mixed overall, with reviews of its doctors being more positive than those about the platform

Dont rush dose increases

Other neuropeptides also provide complementary tools for related research domains

Public health experts note that this market dynamicwhere expensive but highly effective treatments drive consumer interest in more affordable but less potent alternativesreflects broader challenges in American healthcare accessibility

According to one estimate, the number of patients to be treated in the US is on track to reach 30 million by 2030.2 While some of the demand will be met with orally delivered treatments,3 the increase in the US alone could equate to one billion injections per year (Figure 1)